Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The NIH-funded network has launched its first clinical trial in response to the new pandemic.
Monday, May 18 is HIV Vaccine Advocacy Day. Support science. Not sound bites.
By altering the components of the vaccine regimen, researchers drove promising antibody and immune-cell responses.
Calling all U.S. cisgender gay and bi men and trans and gender nonconforming people at risk for the virus.
A major trial has closed down after the experimental vaccine failed both to prevent HIV transmission and to reduce viral load in those who con...
Researchers shuttered a trial after the experimental vaccine failed to both prevent HIV transmission and to reduce viral load in those contrac...
An investigatory vaccine from the Baltimore-based Profectus BioSciences is both safe in humans and prompts an immune response to HIV proteins.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.